APHL seeks to identify and select up to five state or local public health laboratories to assist with the validation of MALDI-TOF for the identification of N. gonorrhoeae.


This funding mechanism provides an opportunity for the development and assessment of a N. gonorrhoeae MALDI-TOF validation panel for use by state or local public health laboratories. Proposals will be evaluated based on the laboratory’s existing capability and facilities and applicants must have:

  • Unrestricted access to a MALDI-TOF Instrument; 
  • Demonstrated competency and capacity using MALDI-TOF to perform bacterial identification; 
  • Demonstrated competency and capacity for bacterial culture including Neisseria species but not limited to N. gonorrhoeae.


July 7, 2017                  RFP Issued
July 31, 2017                Letter of Intent Due to APHL (see below)
August 16, 2017          RFP Responses Due
August 30, 2017          Proposal review completed
September 8, 2017     If needed, follow-up interviews and updated proposals due
September 11, 2017   Final review completed and awardees selected
September 30, 2017   Draft contracts submitted to APHL Legal Dept. for final internal review

Any modification to this anticipated schedule will be posted here (www.aphl.org/rfp) and via an email blast to the public health laboratories (PHLs).

Request for Proposal Materials

The Validation of the MALDI-TOF for the Identification of Neisseria gonorrhoeae RFP provides details on how to complete this RFP. The RFP contains a copy of the scoring criteria that will be used for evaluation of proposals in Appendix C. The details for expectations for MADLI-TOF Validation of N. gonorrhoeae are contained in Appendix A.

Questions and Answers